MACQUARIE GROUP LTD - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$509,000
-25.1%
380,0000.0%0.00%0.0%
Q2 2023$680,000
-54.0%
380,0000.0%0.00%
-50.0%
Q1 2023$1,478,000
+14.4%
380,0000.0%0.00%0.0%
Q4 2022$1,292,000
-38.1%
380,000
-0.4%
0.00%
-33.3%
Q3 2022$2,086,000
+21.1%
381,465
-0.2%
0.00%
+50.0%
Q2 2022$1,723,000
-38.8%
382,0410.0%0.00%0.0%
Q1 2022$2,816,000
+14.7%
382,0410.0%0.00%0.0%
Q4 2021$2,456,000
+10.4%
382,0410.0%0.00%0.0%
Q3 2021$2,224,000
-43.6%
382,0410.0%0.00%
-33.3%
Q2 2021$3,943,000
-1.6%
382,041
+0.3%
0.00%
-50.0%
Q1 2021$4,009,000
-32.1%
381,059
-0.1%
0.01%
-33.3%
Q4 2020$5,903,000
+6.0%
381,3320.0%0.01%0.0%
Q3 2020$5,567,000
-22.9%
381,3320.0%0.01%
-25.0%
Q2 2020$7,222,000
-1.1%
381,332
+0.4%
0.01%
-20.0%
Q1 2020$7,300,000
+0.2%
380,0000.0%0.02%
+50.0%
Q4 2019$7,285,000
+99.3%
380,0000.0%0.01%
+66.7%
Q3 2019$3,656,000
-46.5%
380,000
-66.7%
0.01%
+50.0%
Q2 2019$6,828,000
+207.7%
1,140,000
+200.0%
0.00%0.0%
Q1 2019$2,219,000
-37.7%
380,000
-0.1%
0.00%
-42.9%
Q4 2018$3,564,000
-38.1%
380,300
+12.4%
0.01%
-22.2%
Q3 2018$5,759,000
-0.5%
338,200
-0.7%
0.01%
-10.0%
Q2 2018$5,787,000
+64200.0%
340,600
+37744.4%
0.01%
Q4 2017$9,0009000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders